Pediatrics
Latest News
Cemiplimab Extends Disease-Free Time in Skin Cancer Post-Op
Patients with local or regional cutaneous squamous cell carcinoma are randomly assigned to receive cemiplimab or placebo post-op. Medscape Medical Ne...
Schrödinger Stops Development Of Blood Cancer Therapy After Two Patient Deaths
Schrödinger said on Thursday it has stopped the development of an experimental drug after the death of two patients with a type of blood cancer in an...
Leukemia Relapse: PD-1 Inhibition Shows Mixed Results
Pembrolizumab shows promise but raises risk for graft-vs-host disease in posttransplant leukemia relapse. Medscape Medical News
Pluvicto vs ARPI in Prostate Cancer: Is One Better?
In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line setting for metastatic castra...
Could Consumption of UPFs Up Lung Cancer Risk?
Smoking was a key confounding factor, and outside experts caution against conclusions of causality. Medscape Medical News
Slowing UK Cancer Gains Risk Widening Survival Gap
Medscape News UK
Ruxolitinib Boosts Survival in Resistant GVHD
In steroid-refractory chronic graft-vs-host disease, ruxolitinib shows sustained 3-year benefits. Medscape Medical News
Don’t Reclassify Grade Group 1 Prostate Cancer: New Data
About 16% of men designated GG1 prostate cancer had higher-risk disease, raising their likelihood of dying from the cancer and undermining efforts to...
Does Getting Fit Guard Against Colorectal Cancer?
Mounting evidence highlights the role of physical fitness in protecting against colorectal cancer onset and recurrence. Medscape Medical News
NHS to Fast-Track Patients into mRNA Cancer Vaccine Trial
Over 100 patients in England will be fast-tracked into a trial of a new mRNA cancer vaccine targeting advanced HPV-related head and neck cancers. Med...
Cemiplimab Extends Disease-Free Time in Skin Cancer Post-Op
Schrödinger Stops Development Of Blood Cancer Therapy After Two Patient Deaths
Leukemia Relapse: PD-1 Inhibition Shows Mixed Results
Pluvicto vs ARPI in Prostate Cancer: Is One Better?
Could Consumption of UPFs Up Lung Cancer Risk?
Slowing UK Cancer Gains Risk Widening Survival Gap
Ruxolitinib Boosts Survival in Resistant GVHD
Don’t Reclassify Grade Group 1 Prostate Cancer: New Data
Does Getting Fit Guard Against Colorectal Cancer?
NHS to Fast-Track Patients into mRNA Cancer Vaccine Trial
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago